Summary: For over a century, potassium ions were viewed as mere passengers in the brain—particles that flow through channels to generate electrical signals. However, a new discovery revealed that potassium ion channels also act as a powerful molecular “switch.”
While studying the fruit fly (Drosophila melanogaster), researchers serendipitously found that an ion channel called Alka functions as a membrane receptor that “detects” extracellular potassium as a ligand. This discovery challenges the fundamental biological understanding of K+ and opens new pathways for treating neurological conditions like epilepsy.
Key Facts
- A Serendipitous Breakthrough: The discovery occurred by accident while testing the effects of aspartic acid. Researchers realized the observed changes in brain activity were actually caused by the potassium counter-ion K+ acting as a trigger.
- Alka as a Receptor: The Alka channel is now identified as the first animal ion channel known to open and close in response to extracellular K+ levels, functioning like a sensor rather than just a tunnel.
- AI-Powered Mapping: Using AlphaFold3, the team identified the exact K+ binding site within the Alka channel. The site mimics a “hydrated” environment, allowing the receptor to specifically recognize potassium ions.
- The Epilepsy Connection: In humans, a specific RNA-edited form of the glycine receptor (GlyR) was found to respond to K+ fluctuations. While potassium levels stay stable in healthy brains, they spike during seizures.
- Pathological “Switch”: Because this RNA-edited GlyR is abundant in the brains of patients with temporal lobe epilepsy, it likely acts as a pathological sensor that responds to high K+ levels during episodes.
Source: NINS
Potassium ions (K⁺) are essential for all cells and living organisms. Scientists have long believed that K⁺ merely passes through ion channels and transporters, rather than acting as an extracellular ligand or molecular “switch.” Indeed, there had been no clear evidence that K⁺ functions as a ligand for membrane proteins in animals or plants—until now.
“Unexpectedly, we made this discovery serendipitously while testing the effect of aspartic acid, with K⁺ added as a counter cation, on Alka, an ion channel located in the brain of Drosophila melanogaster,” said Shimomura.
“The compound was effective. At first, we thought the effect was due to aspartic acid, but we ultimately realized that it was caused by K⁺, meaning that Alka functions as a membrane receptor that detects extracellular K⁺ as a ligand.”
Ion channel currents in Alka-expressing cells changed significantly in response to K⁺ levels. The researchers combined electrophysiological analysis with AlphaFold3, an AI-based protein structure prediction tool. This allowed them to identify the K⁺-binding site in Alka. This site creates a chemical environment favorable for K⁺, similar to that found in aqueous solution or in the well-known selectivity filter of K⁺ channels.
Based on these findings in fruit flies, the researchers next investigated whether K⁺ functions similarly in humans by examining the glycine receptor (GlyR), an ion channel related to Alka that is expressed in the human brain. Although changes in extracellular K⁺ concentration did not affect the conventional form of GlyR, they did modulate an RNA-edited form of GlyR, despite its low efficacy. This suggests that K⁺ may also act as a molecular “switch” in humans.
“The K+ binding in GlyR is likely too weak to function under healthy conditions in the human brain, where extracellular K⁺ concentration is maintained within a narrow range of 3–5 mM,” said Suzuki.
“However, these levels can rise abnormally during epileptic episodes. Because the RNA-edited form of GlyR is abundant in the brains of patients with temporal lobe epilepsy, changes in this receptor may represent a mechanism for responding to pathological K⁺ fluctuations.”
This study reveals a novel “switch-type” sensor for extracellular K⁺ levels, complementing the well-known “permeation-type” mechanism. The discovery may help uncover new mechanisms governing extracellular K⁺ homeostasis, clarify links to diseases such as epilepsy, and support the development of therapeutic drugs targeting these K⁺-dependent channels.
Key Questions Answered:
A: In a healthy human brain, extracellular K⁺ is strictly maintained at very low levels (3–5 mM). The “switch” (the GlyR receptor) is designed to be weak enough that it only activates when levels rise abnormally, such as during the intense electrical storms of an epileptic seizure.
A: It adds a whole new layer of communication. We used to think K⁺ only moved to change voltage; now we know it can act like a hormone or a neurotransmitter, signaling the brain to change its behavior based on the chemical environment outside the cells.
A: Yes. By understanding the “K+ switch,” pharmaceutical researchers can develop drugs that specifically target these potassium-dependent channels to help stabilize the brain during neurological emergencies.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience research news
Author: Hayao KIMURA
Source: NINS
Contact: Hayao KIMURA – NINS
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Extracellular K+ modulates the pore conformations of Cys-loop receptor anion channels” by Takushi Shimomura, Yoshihiro Kubo, Minoru Saitoe & Yoshinori Suzuki. Nature Communications
DOI:10.1038/s41467-026-71629-z
Abstract
Extracellular K+ modulates the pore conformations of Cys-loop receptor anion channels
Potassium (K+) is an essential cation for life. Extracellular K+ is mainly sensed by membrane proteins that use K+ as their substrates. Yet, no membrane protein that is gated by extracellular K+ as a ligand and exhibits a distinct signal has been discovered in animals.
Here, we report that a Cys-loop receptor, CG12344/DmAlka, expressed in the Drosophila nervous system, is selectively modulated by a physiological concentration of extracellular K+. Structural prediction, electrophysiology and phylogenetic analysis of DmAlka revealed the extracellular K+ binding site that mimics the hydrated chemical environment for K+, as observed in K+ channel pore.
Furthermore, we found that K+ binding induces a previously unrecognized mode-switching mechanism, altering properties ranging from ligand sensitivity to ion selectivity. Notably, a human glycine receptor variant also exhibited similar mechanisms.
Our study reveals a regulatory mechanism of Cys-loop receptors that directly links the extracellular K+ signaling to Cl− conductance in animals.
